Related Experiment Video
Updated: Apr 10, 2026
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
12.0K
Pharmacogenetics and antipsychotic treatment response
Z Naumovska1, A K Nestorovska1, A Filipce2
1Pharmaceutical Chemistry Institute, Pharmacy Faculty, Ss. Cyril and Methodius University, Skopje, R. Macedonia.
Summary
Genetic variations influence antipsychotic treatment response in schizophrenia. Pharmacogenetic testing can personalize drug selection and dosage, improving efficacy and reducing side effects for better patient outcomes.
Area of Science:
- Pharmacogenomics
- Neuroscience
- Psychiatry
Background:
- Antipsychotic medications are crucial for schizophrenia treatment.
- Treatment non-compliance and morbidity stem from poor response and side effects.
- Genetic factors significantly impact antipsychotic efficacy and safety.
Purpose of the Study:
- To review the molecular basis of schizophrenia treatment response.
- To highlight genetic variations influencing antipsychotic outcomes.
- To explore the clinical utility of pharmacogenetic biomarkers.
Main Methods:
- Literature review of studies on genetic polymorphisms and antipsychotic treatment.
- Analysis of genes involved in drug metabolism (CYP450), transport (ABCB1), and neurotransmission (dopamine, serotonin receptors).
- Examination of genes related to neurotransmitter metabolism and signaling pathways (COMT, BDNF, etc.).
Main Results:
- Functional polymorphisms in CYP450, ABCB1, dopaminergic, and serotonergic genes affect treatment response.
- Genetic variations in neurotransmitter metabolism and G-protein signaling pathways are linked to treatment outcomes.
- Specific gene polymorphisms show potential as biomarkers for predicting drug response and side effects.
Conclusions:
- Pharmacogenetic testing can guide the selection of antipsychotic drugs and optimal dosages.
- Personalized medicine approaches based on genetic profiles can improve treatment efficacy.
- Pharmacogenetics offers a pathway to minimize adverse effects, shorten stabilization time, and enhance schizophrenia prognosis.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
122
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
122
01:29Pharmacogenetics and Pharmacogenomics: Overview
171
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
171
01:27Pharmacogenetics of Drug Metabolism: Overview
147
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
147
01:27Principles of Pharmacogenetics: Types of Genetic Variants
110
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
110
01:26Psychosis: Goals of Pharmacotherapy
674
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
674
01:29Pharmacogenomics: Identification of New Drug Targets
91
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
91